Researchers at Hershey Cancer Institute, at the Penn State University, have stumbled upon a potentially revolutionary discovery in cancer treatment. The research they conducted found that resveratrol, a compound found in grapes, can be an extremely effective cancer fighting weapon.
The study, published in a recent issue of BMC Complementary and Alternative Medicine, states that the combination of resveratrol and grape seed extract is a very potent and effective method of fighting colon cancer cells, and that the combination is not harmful to healthy cells.
Furthermore, the study showed that resveratrol can help with both prevention and possible reoccurrence of cancer in those who were lucky enough to spot the cancer in time and get rid of it.
Lastly, the researchers noted that diet low in red meat, and rich in fruits and vegetables, lowers the risk of colon cancer. This further connects with a plant-based diet that is formed in a way that the patient gets a little bit of different types of plants, different parts of plants, and different colors of plants. They claim that this is not only beneficial to promoting healthy bacterial diversity, but also for prevention of chronic diseases and elimination of colon cancer stem cells.
About Penn State Cancer Institute
Penn State Cancer Institute is committed to fighting cancer on every front; through education and prevention, early detection and diagnosis, effective treatment, and survivorship programs. Their facilities, including the aforementioned Hershey Center, provide patents access to all aspects of canre in a single destination, and that includes:
- Infusion therapy suites and private rooms for chemotherapy
- A state-of-the-art radiation oncology suite that offers treatment options that refine tumor targeting and reduce treatment time
- A chemotherapy and infusion pharmacy staffed by clinical pharmacists and certified pharmacy technicians
- An outdoor healing garden that offers a quiet retreat for patients and their families
Seamlessly integrating these services creates a real-time medicine model that helps ensure each patient receives the right diagnosis and the right therapy at the right time.
In the United States, colon cancer is the third most common type of cancer, in both men and women. Colorectal cancer is a malignant tumor arising from the inner wall of the large intestine or rectum. Common risk factors for this type of cancer include age factor (older people are more prone to this type of cancer), race (African-American race is more at risk of this type of cancer), genetic factor, and previous history of colon issues, such as colon polyps or long-standing ulcerative colitis.
Colon polyps are the most common cause of this type of cancer, and removal of these polyps can aid the prevention of colorectal cancer. Colon polyps and colon cancer might not give any early signs or symptoms, which makes them extremely difficult to treat as they are most often discovered in late stages. Regular colorectal cancer screening is important, and recommended to every person over the age of 40.